Recent HbA1C value-Above 7 - Page 8 of 8 Posts on Medivizor
Navigation Menu

Recent HbA1C value-Above 7 Posts on Medivizor

Addition of insulin glargine to combination therapy with oral anti-diabetic drugs: a promising therapeutic option for type 2 diabetes

Addition of insulin glargine to combination therapy with oral anti-diabetic drugs: a promising therapeutic option for type 2 diabetes

Posted by on May 6, 2014 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effects of adding insulin glargine treatment  to metformin (Glucophage), glimepiride (Amaryl) or their combination in patients with uncontrolled type 2 diabetes mellitus. Some background Hyperglycemia (high blood glucose) in type 2 diabetes mellitus arises from a combination...

Read More

Controlling uncontrolled diabetes

Controlling uncontrolled diabetes

Posted by on Sep 29, 2013 in Diabetes mellitus | 0 comments

In a nutshell This review analyzed the effects of incretin based therapies in combination with insulin as treatment for uncontrolled type 2 diabetes mellitus (T2DM). Some background Non-insulin oral drugs, such as incretin based therapies, are a common treatment for T2DM patients. Incretins are hormones that are normally released by the body in...

Read More

The current state of pancreas transplantation

Posted by on Sep 11, 2013 in Diabetes mellitus | 0 comments

In a nutshell This review analyzed current research regarding pancreas transplantation for diabetic patients. Some background The hormone insulin is produced by the pancreas and is responsible for regulating blood sugar levels. In type 1 diabetes mellitus (T1DM), the pancreas does not produce insulin effectively. In type 2 diabetes mellitus...

Read More

A comparison of the efficacy and safety of an oral versus an injectable treatment for patients with type 2 diabetes mellitus

A comparison of the efficacy and safety of an oral versus an injectable treatment for patients with type 2 diabetes mellitus

Posted by on Aug 1, 2013 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated whether an oral dose of sitagliptin was as effective as an injectable dose of liraglutide in patients with type 2 diabetes mellitus (T2DM) uncontrolled with metformin alone. Some background Patients with T2DM do not produce enough insulin (or are resistant to insulin) to break down the glucose they take in from...

Read More

A variety of medications for type 2 diabetes: comparison of the efficacy and drawbacks

A variety of medications for type 2 diabetes: comparison of the efficacy and drawbacks

Posted by on Mar 7, 2013 in Diabetes mellitus | 0 comments

In a nutshell The aim of this review was to summarize the benefits and harms of several drugs commonly used for the treatment of adults with type 2 diabetes mellitus (T2DM). Some background Treatment for T2DM usually starts with diet changes and exercise because it is largely associated with obesity. Treating T2DM with medications aims to...

Read More

Long acting insulin versus sitagliptin (Januvia) in type 2 diabetes not controlled with metformin (Glucophage) alone

Posted by on Feb 23, 2013 in Diabetes mellitus | 0 comments

In a nutshell This study compared the safety and efficacy of Insulin glargine (Lantus) versus Sitagliptin (Januvia) in the management of type 2 diabetes mellitus (T2DM) poorly controlled by Metformin (Glucophage) alone. Main findings: insulin glargine provides better glycemic control than Sitagliptin when added to Metformin therapy. Some...

Read More

Efficacy and Safety of Dapagliflozin (Forxiga) in Type 2 Diabetics Treated with High Doses of Insulin

Efficacy and Safety of Dapagliflozin (Forxiga) in Type 2 Diabetics Treated with High Doses of Insulin

Posted by on Feb 23, 2013 in Diabetes mellitus | 0 comments

In a nutshell This trial assessed the efficacy and safety of a new diabetes drug, Dapagliflozin (Forxiga). Results revealed that the drug helps control difficult cases of type 2 diabetes with only moderate side-effects. Some background Dapagliflozin is a drug recently approved by the European Medicines Agency for the treatment of diabetes. Its...

Read More